Next-Generation Sequencing
The latest news on next-generation sequencing.
Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer
Syapse will analyze data from single-gene, small panel, and comprehensive genomic profiling tests in the community oncology setting, with input from Illumina.
Euformatics Gains CE-IVD Mark for OmnomicsNGS
Euformatics has updated the marking on its variant interpretation and reporting software as the firm prepares for the EU's new IVDR scheme.
The firm worked with Genomics England and Rady Children's Institute to collect data about the efficacy of its AI-based genetic test software.
Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
Premium
As economic and practical challenges of next-gen sequencing have eased in recent years, more groups are bringing comprehensive cancer genomic testing in house.
Palmetto Finalizes Medicare Coverage for MRD Cancer Testing
To receive coverage, the patient must have a personal history of cancer where the type and staging are within the intended use of the test.